Ignite Creation Date:
2024-05-06 @ 6:42 PM
Last Modification Date:
2024-10-26 @ 2:53 PM
Study NCT ID:
NCT05752591
Status:
COMPLETED
Last Update Posted:
2024-03-15
First Post:
2023-02-20
Brief Title:
Hypothalamic-pituitary Dysfunction in Diabetes
Sponsor:
Istituto Auxologico Italiano
Organization:
Istituto Auxologico Italiano
Study Overview
Official Title:
Study of the Hypothalamic-pituitary Dysfuntion in Patients With Diabetes Mellitus
Status:
COMPLETED
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
DIAPO
Brief Summary:
Type 2 Diabetes mellitus T2DM is a chronic disease with a high prevalence and several comorbidities impacting on public health and society Among the complications of T2DM it has been showed a high prevalence of hypogonadotropic hypogonadism Even if hypogonadism is associated to a worse metabolic profile and cardiovascular risk it is discussed whether and when to treat this potentially reversible form associated to diabetes In fact the pathogenic mechanism of this condition in diabetic patients is not fully understood and its clinical correlates including the prevalence of other possible associated hypothalamic-pituitary axes dysfunctioning questioned The aim of the present study is to assess with an observational cross sectional study on a large series of type 2 diabetic patients enrolled consecutively all the suspected etiologies of this complication in one single evaluation both acquired and genetic congenital predisposition its clinical correlates and the real prevalence of the disease using the lastly validated criteria for late onset hypogonadotropic hypogonadism
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None